More than 97% of human papilloma virus type 16 (hpv-16) was found with chrysotile asbestos & relatively smooth round tumor outline, and less than 3% was found with hpv-18 and tremolite asbestos & irregular sawtooth-like zigzag outline in breast cancer tissues in over 500 mammograms of female patients: Their implications in diagnosis, treatment, and prevention of breast cancer

Acupuncture and Electro-Therapeutics Research

Volumn 38, Issue 3-4, 2013, Pages 211-230

  Omura, Yoshiaki ^a   Jones, Marilyn K ^b   Nihrane, Abdallah ^c   Duvvi, Harsha ^d   Shimotsuura, Yasuhiro ^e   Ohki, Motomu ^f  

^a MANHATTAN COLLEGE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e International College of Acupuncture and Electro therapeutics   (United States)

^f ORT Life Science Research Institute   (Japan)

Author keywords

Breast cancer; Chrysotile asbestos; Electro magnetic field resonance phenomenon.; Human papillomavirus 16 (hpv 16); Human papillomavirus 18 (hpv 18); Monoclonal antibody; Tremolite asbestos

Indexed keywords

AMPHIBOLE; CHRYSOTILE; TREMOLITE;

ARTICLE; BREAST TUMOR; CHEMISTRY; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ISOLATION AND PURIFICATION; MAMMOGRAPHY; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; BREAST NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MAMMOGRAPHY; MIDDLE AGED;

EID: 84891945750     PISSN: 03601293     EISSN: None     Source Type: Journal    
DOI: 10.3727/036012913X13831832269324     Document Type: Article

References (54)

1. "Sexually Transmitted Diseases (SDS); Genital HPV Infection- CDC Fact Sheet." Centers for Disease Control and Prevention (CDC), pp. 1-6. July 2013. http://www.cdc.gov/std/hpv/stdfact-hpv.htm
2. Di Lonardo A, Venuti A, Marcante ML. "Human papillomavirus in breast cancer." Breast Cancer Research and Treatment. Vol.21 (2): 95-100, 1992.
3. Liu Y, Klimberg VS, Andrew NR, et al. "Human Papillomavirus DNA is Present in a Subset of Unselected Breast Cancers." Journal of Human Virology. Vol.4: 329-334, 2001. (Pubitemid 34693880)
4. Kroupis C, Markou A, Vourlidis N, et al. "Presence of High-Risk Human Papillomavirus Sequences in Breast Cancer Tissues and Association with Histopathological Characteristics." Clinical Biochemistry. Vol.39: 727-731, 2006. (Pubitemid 44036781)
5. Gumus M, Yumuk PF, Salepci T, et al. "HPV DNA Frequency and Subset Analysis in Human Breast Cancer Patients' Normal and Tumoral Tissue Samples. "Journal of Experimental & Clinical Cancer Research. Vol.25: 515-521, 2006. (Pubitemid 46166765)
6. Amarante MK, Watanabe MA. "The possible involvement of virus in breast cancer." Journal of Cancer Research and Clinical Oncology, Vol.135 329-337, 2009.
7. Heng B, Glenn WK, Ye Y, et al. "Human papillomavirus is associated with breast cancer." British Journal of Cancer, Vol.101 1345-1350, 2009.
8. Wang X, Tian X, Liu F, et al. "Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: A descriptive study." BMC Cancer. Vol.10 19, 2012.
9. Castle PE, Katki HA. "Benefits and risks of HPV testing in cervical cancer screening." The Lancet Oncology, Voll 1: 214-215, 2010.
10. Omura, Y. "A new, simple, non-invasive technique of internal organs and various cancer tissues using extended principles of the 'Bi-Digital O-Ring Test' without using expensive imaging instruments or exposing the patient to any undesirable Radiation-Part 1." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 10 no.2 pp. 255-257, 1985.
11. Omura, Y. " Electro-Magnetic Resonance Phenomenon as a Possible Mechanism Related to the 'Bi-Digital O-Ring Test Molecular Identification and Localization Method." Acupuncture & Electro Therapeutics Research. The International Journal. Vol. 11, no.2, pp. 127-145, 1986. (Pubitemid 17206524)
12. Omura, Y. "2-3 minute screening of cancer and localization of the cancer using X-Y-Axis laser line scanning of the whole body, and effective treatment of cancer using selective drug uptake enhancement method including semi-permanent acupuncture on true St. 36, which markedly reduces cancer cell telomere and enhances normal cell telomere." Acupuncture & Electro-Therapeutics Research., The International Journal. Vol. 273&4,pp. 237-240, 2002.
13. Omura, Y. "Beneficial effects & side effects of DHEA: True anti-aging & age-promoting effects, as well as anti-cancer & cancer-promoting effects of DHEA evaluated from the effects on the normal & cancer cell telomeres & other parameters. " Acupuncture & Electro-Therapeutics Research, International Journal, Vol. 30, Nos. 3&4, pp. 219-261,2005.
14. Omura, Y. "Reduced Glucose Uptake With Markedly Increased Gastrin Releasing Peptide, Osteopontine & Asbestos Found in Dark Black Areas of PET Scan of Chest Wall in Patient with Mesothelioma " Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 31, pp 247-257, 2006. (Pubitemid 46979993)
15. Omura, Y. "Asbestos as a Possible Major Cause of Not Only Malignant Lung Tumors (Including Small Cell Carcinoma, Adenocarcinoma & Mesothelioma), but Also Brain Tumors (ie. Astrocytoma & Glioblastoma Multiforme), Many Other Malignant Tumors, Some Types of Intractable Pain Including Fibromyalgia, & Some Cardio- Vascular Pathology: Safe & Effective Methods of Reducing Asbestos from Normal & Pathological Areas." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 31, pp 61-125, 2006. (Pubitemid 44499768)
16. Omura, Y. "Rapid screening & diagnosis of various cancers from human voice using Bi-Digital O-Ring test resonance phenomenon between 2 identical substances i.e. between microscopic slide of specific cancer tissue & cancer information in the sound of human voice, and detection of myocardial damage & infection from human voice." Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 32(3/4), pp 235-270, 2007.
17. Omura, Y. "Non-invasive quick diagnosis and safe & effective treatment of intractable medical problems: Anti-aging and anti-cancer," pp. 16-20 in the 102-page Book of Abstracts & Program for the Nishinomiya-Yukawa International & Interdisciplinary Symposium, entitled What Is Life? The Next 100 Years of Yukawa's Dream. Organized by Yukawa Institute for Theoretical Physics, Kyoto University, held in Kyoto, Japan, October 15-20, 2007.
18. Shimotsuura, Y., Omura, Y. "Case Reports of Clinical Cancer Found by Standard Laboratory Tests Several Years After Positive Findings by Bi-Digital O-Ring Test." Acupuncture and Electro Therapeutics Research, The International Journal. Vol. 33(1/2), pp. 54-55,2008. (Pubitemid 351912213)
19. Omura, Y. "Non-invasive 6 minute screening of malignant tumors (including mesothelioma), cardiovascular disease, alzheimer's disease, or autism: Their safe, effective treatment using one optimal dose of DHEA." Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 33(1/2) pp. 56-57, 2008.
20. Omura, Y. "Clinically very significant normal cell telomere increasing effect and cancer cell telomere reducing effect of some electromagnetic field neutralizers (EMF neutralizers by aulterra, MICA processed thin copper sheet, EMF protector 'X,' guard plus, etc.): Short-time & long-time effect by the application of electromagnetic field neutralizer on normal tissue and acupuncture points including most significant effect at true ST. 36 and SP. 6." Acupuncture and Electro-Therapeutics Research. The International Journal. Vol. 33(3/4) pp. 227-230, 2008.
21. th. pp 15 -17, 2009
22. Omura, Y; Chen, Y; Lermand, O; Jones, M; Duvvi, H; Shimtosuura, Y. "Effects of transcutaneous electrical stimulation (1 pulse/sec) through custom-made disposable surface electrodes covering omura's ST36 area of both legs on normal cell telomeres, Oncogen C-fos Ab2, Integrin a5bl, chlamydia trachomatis, etc. in breast cancer & alzheimer patients." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 35(3/4) pp. 147-186, 2010.
23. Omura, Y; Lu, DP; Jones, M; O'Young B; Duvvi, H; Paluch, K; Shimotsuura, Y; Ohki, M. "New clinical findings on the longevity gene in disease, health, & longevity: Sirtuin 1 often decreases with advanced age & serious diseases in most parts of the human body, while relatively high & constant sirtuin 1 regardless of age was first found in the hippocampus of supercentenarians." Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine, Vol. 36(3/4) pp. 287-309, 2011.
24. Omura, Y; O'Young, B; Jones, M; Nihrane A; Duvvi, H; Paluch, K; Shimotsuura, Y; Ohki, M. "Newly discovered quick, non-invasive screening method of bone marrow malignancies including various leukemia's, hodgkin's lymphoma, non-hodgkin's lymphoma, & multiple myeloma from abnormal small rectangular area within bone marrow organ representation areas of the face." Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine, Vol. 37 (1) pp. 13-47, 2012.
25. Omura, Y, "Chapter 41: profound evidence for disease associations." 777-798, in 888 page book, Advancing Medicine with Food and Nutrients, Second Edition, CRC 2013
26. Omura Y, Jones M, Duvvi H, Paluch K, Shimotsuura Y, Ohki M. "Factors significantly increasing or inhibiting early stages of malignant melanoma (M.M.) and non-invasive evaluation of new treatment by ingestion and external application of optimal doses of the most effective anti-M.M. substances: Haritaki, cilantro, vitamin D3, nori, EPA with DHA, & application of special (+) solar energy stored paper, which reduced the M.M. active area & asbestos rapidly." Omura Y, Jones M, Duvvi H, Paluch K, Shimotsuura Y, Ohki M. Acupuncture Electrotherapy Research. International Journal of Integrated Research, Vol.38 (1-2): 37-76, 2013.
27. D'Abramo C.M., Archambault J. "Small molecule inhibitors of human papillomavirus protein - protein interactions." Open Virology Journal. Vol.5 80-95, 2011.
28. Band, V., Zajchowski, D., Kulesa, K., Sager, R. "Human papillomavirus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements." Proceedings of the National Academy of Sciences. Vol.87 463-467, 1990. http://www.pnas.Org/content/87/1/463. short#cited-by
29. Ostrow, R., Manias, D., Fong, W., Zachow, K., and Faras, A. "A Survey of Human Cancers for Human Papillomavirus DNA by Filter Hybridization." Cancer. Vol.59: 429-434, 1987. (Pubitemid 17002419)
30. Lowy DR, Schiller JT. "Prophylactic human papillomavirus vaccines." Journal of Clinical Investigation. Vol. 116 (5): 1167-1173, 2006.doi: 10.1 172/JCI28607.
31. "Silgard european public assessment report". European Medicines Agency. September 25, 2009.
32. Muñoz N, Bosch FX, Castellsagué X (August 2004). "Against which human papillomavirus types shall we vaccinate and screen? The international perspective". International Journal of Cancer. Vol.l11 (2): 278-285 doi: 10.1002/ijc.20244. PMID 15197783.
33. Waknine, Yael (October 2, 2006). "International Approvals: Singulair and Gardasil/Silgard". Medscape Today. 2006.
34. Markowitz, LE; Dunne, EF; Saraiya, M; Lawson, HW; Chesson, H; Unger, ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). "Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control; Vol.56 (RR-2): 1-24, 2007.
35. Centers for Disease Control and Prevention (CDC). "FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)". Morbidity and mortality weekly report. Vol.59 (20): 630-632, 2010
36. Centers for Disease Control and Prevention (CDC). "FDA licensure of bivalent human papillomavirus vaccine (HPVI, Ceravrix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)." Morbidity and mortality weekly report, Vol.59 (20): 626-629. 2010.
37. Cortez, Michelle Fay; Pettypiece, Shannon (13 November 2008). "Merck cancer shot cuts genital warts. Lesions in men (Update2)". Bloomberg News, 2009.
38. "FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers" (Press release). U.S. Food and Drug Administration (FDA). 2008
39. Amarante MK, Watanabe MA. "The possible involvement of virus in breast cancer." Journal of Cancer Research and Clinical Oncology. Voll 35: 329-337, 2009.
40. Manir S, D'Souza G, Westra WH, et al. "HPV-associated head and neck cancer: A virus-related cancer epidemic." The Lancet Oncology. Vol. 11:781-789,2010.
41. Heath, M, Bowyer, K, Kegelmeyer, WP, Kopans, D, and Kyong Chang, Moore, R, and S. Munishkumaran. "Current status of the digital database for screening mammography." digital mammography. 457-460, 1998. Kluwer Academic Publishers; Proceedings of the Fourth International Workshop on Digital Mammography http://marathon.csee.usf.edu/Mammography/Database.html
42. Heath, M, Bowyer, K, Kegelmeyer, WP Kopans D, and Moore, R. The digital database for screening mammography, Proceedings of the Fifth International Workshop on Digital Mammography. M.J. Yaffe, ed., Medical Physics Publishing, 212-218, 2001. http://marathon.csee.usf.edu/Mammography/Database.html
43. Kopans, D, Moore, R, Bowyer, K, Kegelmeyer, P, Shile, P. University of Florida Digital Mammography, Home Page 4, http://marathon.csee.usf.edu/ Mammography/Database.html
44. Chang, P., Wang, T., Yao, Q., Lv, Y., Zhang, J., Guo, W., Wang, L., Chen, J. "Absence of human papillomavirus in patients with breast cancer in north-west China." Medical Oncology. Vol.29 521-525, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21499926
45. Mou, X. "Low prevalence of human papillomavirus (HPV) in Chinese patients with breast cancer." Journal of International Medical Research. Vol.39 1636-1644, 2011. http://imr.sagepub.com/content/39/5/1636.long
46. Wrede, D. "Absence of HPV 16 and 18 DNA in breast cancer." British Journal of Cancer. Vol.65 891-894, 1992. http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC1977759/pdf/bricancer00070-0107.pdf
47. Silva RG Jr, da Silva BB. "No evidence for an association of human papillomavirus and breast carcinoma." Breast Cancer Research and Treatment. Vol.125 261-264, 2011.
48. Hachana M, Ziadi S, Amara K, et al. "No evidence of human papillomavirus DNA in breast carcinoma in Tunisian patients." The Breast, Vol.19 541-544, 2010.
49. Lindel K, Forster A, Altermatt HJ, et al. "Breast cancer and human papillomavirus (HPV) infection: No evidence of a viral etiology in a group of Swiss women." The Breast.vol.16 172-177, 2007.
50. Yavuzer D, Salepci T, Karadayi N, et al. "Human papillomavirus is not associated with breast carcinoma." Breast Cancer Research and Treatment. Vol.122: 899-900, 2010.
51. De Cremoux P, Thioux M, Lebigot I, et al. "No evidence of human papillomavirus DNA sequences in invasive breast carcinoma." Breast Cancer Research and Treatment. Vol.109: 55-58, 2008. (Pubitemid 351538756)
52. Omura Y. United States Patent No. 5188107. Issued: February 23, 1993.
53. Figure 7 molecular structure: http://www.csa.com/discoveryguides/ asbestos/review5.php#v1
54. Figure 7 rock pictures: http://en.wikipedia.Org/wiki/File:Chrysotile.jpg; http://en.wikipedia.org/wiki/File:Tremolite-Campolungo.jpg